Emma Aarnio

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Härkönen, Ulla; Rannanheimo, Piia; Leppänen, Laura; Aarnio, Emma. Sic! 3/2021: 5 s,. 2021

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. Bmc health services research 21 1: 916. 2021

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Jalkanen, Kari; Järvenpää, Riia; Tilles-Tirkkonen, Tanja; Martikainen, Janne; Aarnio, Emma; Männikkö, Reija; Rantala, Eeva; Karhunen, Leila; Kolehmainen, Marjukka; Harjumaa, Marja; Poutanen, Kaisa; Ermes, Miikka; Absetz, Pilvikki; Schwab, Ursula; Lakka, Timo; Pihlajamäki, Jussi; Lindström, Jaana; The StopDia Study Group. JMIR diabetes 6 3: e21356. 2021

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla

Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. Lääkärilehti 76 1-2: 48-52. 2021

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. Frontiers in pharmacology 12: 687549. 2021

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. Biomedicines 9 9: 1280. 2021

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. Biomedicines 9 12: 1800. 2021

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Aarnio, Emma; Huupponen, Risto; Martikainen, Jaana E; Korhonen, Maarit J. Research in social and administrative pharmacy 16 4: 553-559. 2020

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. Bmc health services research 20: 1095. 2020

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. Health policy 124 12: 1310-1316. 2020

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Sääskilahti, Maria; Aarnio, Emma; Lämsä, Elina; Ahonen, Riitta; Timonen, Johanna. Journal of pharmaceutical health services research 11 4: 335-342. 2020

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Wimmer Jr, Gejza; Murin, Jan; Paduchova, Martina; Tesar, Tomas; Hlinkova, Lubica; Slavkovsky, Peter; Aarnio, Emma. Drugs and aging 37 8: 595-604. 2020

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Wawruch, Martin; Wimmer, Gejza Jr; Murin, Jan; Paduchova, Martina; Petrova, Miriam; Tesar, Tomas; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. Biomedicines 8 10: 378. 2020

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J. Health and quality of life outcomes 17: 117. 2019

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Suviranta, T; Timonen, J; Martikainen, J; Aarnio, E. Bmc health services research 19: 769. 2019

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Törmälehto, S; Aarnio, E; Mononen, ME; Arokoski, JPA; Korhonen, RK; Martikainen, JA. PLoS ONE 14 7: e0219902. 2019

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Wawruch M; Wimmer G Jr; Murin J; Paduchova M; Tesar T; Hlinkova L; Slavkovsky P; Fabryova L; Aarnio E. Drugs and aging 36 9: 863-873. 2019

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Aarnio, Emma; Huupponen, Risto; Hämeen-Anttila, Katri; Merikoski, Merja; Puhakka, Jaana; Korhonen, Maarit J. Basic and clinical pharmacology and toxicology 2019; 124 4: 416-422. 2018

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Törmälehto, Soili; Mononen, Mika E; Aarnio, Emma; Arokoski, Jari P A; Korhonen, Rami K; Martikainen, Janne. Health and quality of life outcomes 16: 154. 2018

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Aarnio Emma. Publications of the University of Eastern Finland. Dissertations in Health Sciences 386. 2017

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Aarnio Emma, Martikainen Janne, Winn Aaron N, Huupponen Risto, Vahtera Jussi, Korhonen Maarit J. Circulation: Cardiovascular Quality and Outcomes 9 6: 704-713. 2016

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Aarnio Emma, Martikainen Janne. Sic! Lääketietoa Fimeasta 6 1: 48-49. 2016

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Aarnio Emma, Korhonen Maarit J, Huupponen Risto, Martikainen Janne. ATHEROSCLEROSIS 239 1: 240-247. 2015

Measurement of statin exposure in the absence of information on prescribed doses

Romppainen Tomi, Rikala Maria, Aarnio Emma, Korhonen Maarit J, Saastamoinen Leena K, Huupponen Risto. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 70: 1275-1276. 2014

Register-based predictors of adherence among new statin users in Finland

Aarnio Emma J, Martikainen Janne A, Helin-Salmivaara Arja, Huupponen Risto K, Hartikainen Juha E.K, Peura Piia K, Korhonen Maarit J. Journal of Clinical Lipidology 2014:8: 117-125. 2013

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Purmonen Timo, Pänkäläinen Emma, Turunen Juha, Asseburg Christian, Martikainen Janne. ACTA ONCOLOGICA 50: 344 - 352. 2011

Tutkimusryhmät

Projektit

Avainsanat

Julkaisut

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Emma Aarnio

Tutkimusryhmät

Projektit

Avainsanat

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet ­ tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla